In an immune competent HNSCC model, fractionated RT (2 Gy × 10) induced PD-L1 upregulation on tumor and infiltrating inflammatory cells as monitored by immunoPET/CT imaging using Zr-89 labeled anti-mouse PD-L1 mAb [31]. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.